Leading Kidney Care Platform

International continues to deliver adjusted Ol¹ growth $ in millions ลลง -$3 -$46 2017 2018 $2 2019 $23 $34 2020 9/30/2021 LTM Non-GAAP measure. See appendix for reconciliation of this non-GAAP measure to the most comparable GAAP measure. From the midpoint of 2021 and 2025 adjusted guidance 46 © 2021 DaVita Inc. All rights reserved. Expect continued adjusted operating income growth of $10-20M per year² *

View entire presentation